Lantheus Holdings, Inc.LNTHEarnings & Financial Report
Lantheus Holdings, Inc. is a global healthcare firm specializing in the development, manufacturing and commercialization of innovative diagnostic imaging agents and related solutions. Its offerings cover core medical segments including oncology, cardiology and urology, with primary markets across North America and other key global regions.
LNTH Q4 FY2025 Key Financial Metrics
Revenue
$406.8M
Gross Profit
$240.9M
Operating Profit
$77.2M
Net Profit
$54.1M
Gross Margin
59.2%
Operating Margin
19.0%
Net Margin
13.3%
YoY Growth
4.0%
EPS
$0.86
Lantheus Holdings, Inc. Q4 FY2025 Financial Summary
Lantheus Holdings, Inc. reported revenue of $406.8M (up 4.0% YoY) for Q4 FY2025, with a net profit of $54.1M (up 558.8% YoY) (13.3% margin). Cost of goods sold was $165.9M, operating expenses totaled $163.7M.
Key Financial Metrics
| Total Revenue | $406.8M |
|---|---|
| Net Profit | $54.1M |
| Gross Margin | 59.2% |
| Operating Margin | 19.0% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
Lantheus Holdings, Inc. Q4 FY2025 revenue of $406.8M breaks down across 7 segments, led by Radiopharmaceutical Oncology at $240.2M (59.0% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Radiopharmaceutical Oncology | $240.2M | 59.0% |
| Definity | $85.3M | 21.0% |
| Strategic Partnerships And Other | $23.3M | 5.7% |
| Techne Lite | $21.0M | 5.2% |
| Licenseand Royalty Revenues | $17.4M | 4.3% |
| Other | $13.6M | 3.4% |
| Other Precision Diagnostics | $5.9M | 1.5% |
Lantheus Holdings, Inc. Revenue by Segment — Quarterly Trend
Lantheus Holdings, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Radiopharmaceutical Oncology and Definity) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Radiopharmaceutical Oncology | $240.2M | $240.6M | $250.6M | $257.7M |
| Definity | $85.3M | $81.8M | $83.9M | $79.2M |
| Strategic Partnerships And Other | $23.3M | $13.7M | $11.6M | $10.7M |
| Techne Lite | $21.0M | $21.1M | $25.0M | $19.7M |
| Licenseand Royalty Revenues | $17.4M | $7.3M | $3.5M | $5.8M |
Lantheus Holdings, Inc. Annual Revenue by Year
Lantheus Holdings, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.5B).
Lantheus Holdings, Inc. Quarterly Revenue & Net Profit History
Lantheus Holdings, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $406.8M | +4.0% | $54.1M | 13.3% |
| Q3 FY2025 | $384.0M | +1.4% | $27.8M | 7.2% |
| Q2 FY2025 | $378.0M | -4.1% | $78.8M | 20.8% |
| Q1 FY2025 | $372.8M | +0.8% | $72.9M | 19.6% |
| Q4 FY2024 | $391.1M | +10.5% | $-11.8M | -3.0% |
| Q3 FY2024 | $378.7M | +18.4% | $131.1M | 34.6% |
| Q2 FY2024 | $394.1M | +22.5% | $62.1M | 15.8% |
| Q1 FY2024 | $370.0M | +23.0% | $131.1M | 35.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $370.0M | $394.1M | $378.7M | $391.1M | $372.8M | $378.0M | $384.0M | $406.8M |
| YoY Growth | 23.0% | 22.5% | 18.4% | 10.5% | 0.8% | -4.1% | 1.4% | 4.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.83B | $1.94B | $2.05B | $1.98B | $2.06B | $2.12B | $2.28B | $2.23B |
| Liabilities | $885.8M | $913.1M | $869.9M | $892.3M | $891.0M | $949.3M | $1.16B | $1.14B |
| Equity | $945.5M | $1.03B | $1.18B | $1.09B | $1.16B | $1.17B | $1.12B | $1.09B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $127.2M | $84.7M | $175.1M | $157.7M | $107.6M | $87.1M | $105.3M | $90.2M |